Healthcare provider profile · identity verified

Edwin Solis Bazan, MD

General Practice · ARROYO, PR · NPI 1245301365

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	454	82
Gabapentin	Gabapentin	447	74
Atorvastatin Calcium	Atorvastatin Calcium	377	117
Synthroid	Levothyroxine Sodium	350	53
Pantoprazole Sodium	Pantoprazole Sodium	296	61
Omeprazole	Omeprazole	287	51
Allopurinol	Allopurinol	240	46
Losartan Potassium	Losartan Potassium	231	66
Amlodipine Besylate	Amlodipine Besylate	225	74
Temazepam	Temazepam	217	29
Rosuvastatin Calcium	Rosuvastatin Calcium	200	62
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	177	75
Levothyroxine Sodium	Levothyroxine Sodium	177	33
Metformin Hcl	Metformin Hcl	175	52
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	145	70
Diclofenac Potassium	Diclofenac Potassium	145	59
Furosemide	Furosemide	142	34
Alendronate Sodium	Alendronate Sodium	138	24
Tamsulosin Hcl	Tamsulosin Hcl	135	24
Azithromycin	Azithromycin	129	97
Diclofenac Sodium	Diclofenac Sodium	123	72
Simvastatin	Simvastatin	110	34
Clonazepam	Clonazepam	109	20
Latanoprost	Latanoprost	107	18
Lisinopril	Lisinopril	106	30
Meloxicam	Meloxicam	97	41
Fluticasone Propionate	Fluticasone Propionate	85	27
Metoprolol Succinate	Metoprolol Succinate	84	28
Donepezil Hcl	Donepezil Hcl	81	14
Glimepiride	Glimepiride	71	19
Pregabalin	Pregabalin	71	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	18
Buspirone Hcl	Buspirone Hcl	59	19
Clopidogrel	Clopidogrel Bisulfate	58	12
Sertraline Hcl	Sertraline Hcl	57	22
Valsartan	Valsartan	54	14
Carvedilol	Carvedilol	52	14
Dexamethasone	Dexamethasone	51	39
Clorazepate Dipotassium	Clorazepate Dipotassium	47	17
Alprazolam	Alprazolam	46	11
Silver Sulfadiazine	Silver Sulfadiazine	46	18
Enalapril Maleate	Enalapril Maleate	43	13
Pioglitazone Hcl	Pioglitazone Hcl	42	12
Spironolactone	Spironolactone	42	11
Doxazosin Mesylate	Doxazosin Mesylate	41	12
Fenofibrate	Fenofibrate	39	suppressed
Finasteride	Finasteride	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Eliquis	Apixaban	37	suppressed
Timolol Maleate	Timolol Maleate	37	suppressed
Baclofen	Baclofen	36	14
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	28
Irbesartan	Irbesartan	34	suppressed
Sulindac	Sulindac	34	11
Sure Comfort	Syringe And Needle,insulin,1ml	33	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Raloxifene Hcl	Raloxifene Hcl	32	suppressed
Trazodone Hcl	Trazodone Hcl	32	suppressed
Etodolac	Etodolac	31	13
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	30	suppressed
Mometasone Furoate	Mometasone Furoate	29	18
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	14
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Nabumetone	Nabumetone	25	12
Methylprednisolone	Methylprednisolone	24	22
Nifedipine Er	Nifedipine	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Mupirocin	Mupirocin	22	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	15
Ketoconazole	Ketoconazole	21	suppressed
Levofloxacin	Levofloxacin	21	17
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	21	16
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Bumetanide	Bumetanide	20	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	20	18
Atenolol	Atenolol	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	14
Farxiga	Dapagliflozin Propanediol	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Prednisone	Prednisone	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Cephalexin	Cephalexin	16	14
Chlorthalidone	Chlorthalidone	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Naproxen	Naproxen	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Ramipril	Ramipril	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Fluorometholone	Fluorometholone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Metolazone	Metolazone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error